Detalhe da pesquisa
1.
MicroRNA networks in FLT3-ITD acute myeloid leukemia.
Proc Natl Acad Sci U S A
; 119(16): e2112482119, 2022 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35412895
2.
PRMT1-mediated FLT3 arginine methylation promotes maintenance of FLT3-ITD+ acute myeloid leukemia.
Blood
; 134(6): 548-560, 2019 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31217189
3.
Cytokine gene polymorphisms are associated with response to blinatumomab in B-cell acute lymphoblastic leukemia.
Eur J Haematol
; 106(6): 851-858, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33721333
4.
Current Management and New Developments in the Treatment of Myelodysplastic Syndrome.
Cancer Treat Res
; 181: 115-132, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34626358
5.
Outcome of Allogeneic Hematopoietic Cell Transplantation after Venetoclax and Hypomethylating Agent Therapy for Acute Myelogenous Leukemia.
Biol Blood Marrow Transplant
; 26(12): e322-e327, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32866594
6.
Outcomes of Allogeneic Hematopoietic Cell Transplantation after Salvage Therapy with Blinatumomab in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia.
Biol Blood Marrow Transplant
; 26(6): 1084-1090, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32035275
7.
Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplant with Fludarabine and Melphalan Conditioning and Tacrolimus/Sirolimus as Graft-versus-Host Disease Prophylaxis in Patients with Acute Lymphoblastic Leukemia.
Biol Blood Marrow Transplant
; 26(8): 1425-1432, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32416253
8.
Long-Term Outcomes of Patients with Acute Myelogenous Leukemia Treated with Myeloablative Fractionated Total Body Irradiation TBI-Based Conditioning with a Tacrolimus- and Sirolimus-Based Graft-versus-Host Disease Prophylaxis Regimen: 6-Year Follow-Up from a Single Center.
Biol Blood Marrow Transplant
; 26(2): 292-299, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31536825
9.
Venetoclax and hypomethylating agents in FLT3-mutated acute myeloid leukemia.
Am J Hematol
; 95(10): 1193-1199, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32628327
10.
Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial.
Lancet Oncol
; 20(7): 984-997, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31175001
11.
Post-Allogeneic Hematopoietic Stem Cell Transplantation Eculizumab as Prophylaxis Against Hemolysis and Thrombosis for Patients with Hematologic Disorders Associated with Paroxysmal Nocturnal Hemoglobinuria Clones.
Biol Blood Marrow Transplant
; 25(5): e183-e185, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30708188
12.
Cytokine Release Syndrome With the Novel Treatments of Acute Lymphoblastic Leukemia: Pathophysiology, Prevention, and Treatment.
Curr Oncol Rep
; 21(1): 4, 2019 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30666425
13.
Phase 1 studies of central memory-derived CD19 CAR T-cell therapy following autologous HSCT in patients with B-cell NHL.
Blood
; 127(24): 2980-90, 2016 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-27118452
14.
Therapy-related acute lymphoblastic leukemia has distinct clinical and cytogenetic features compared to de novo acute lymphoblastic leukemia, but outcomes are comparable in transplanted patients.
Haematologica
; 103(10): 1662-1668, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29903756
15.
Results of a phase 1 study of quizartinib as maintenance therapy in subjects with acute myeloid leukemia in remission following allogeneic hematopoietic stem cell transplant.
Am J Hematol
; 93(2): 222-231, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29090473
16.
Identifying signs and symptoms of AL amyloidosis in electronic health records using natural language processing, diagnosis codes, and manually abstracted registry data.
Am J Hematol
; 98(9): E255-E258, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37403432
17.
Phase I Trial of Total Marrow and Lymphoid Irradiation Transplantation Conditioning in Patients with Relapsed/Refractory Acute Leukemia.
Biol Blood Marrow Transplant
; 23(4): 618-624, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28087456
18.
Favorable impact of allogeneic stem cell transplantation in patients with therapy-related myelodysplasia regardless of TP53 mutational status.
Haematologica
; 102(12): 2030-2038, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28971906
19.
Influence of Absorption, Distribution, Metabolism, and Excretion Genomic Variants on Tacrolimus/Sirolimus Blood Levels and Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 22(2): 268-276, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26325438
20.
Outcome of secondary acute myeloid leukemia treated with hypomethylating agent plus venetoclax (HMA-Ven) or liposomal daunorubicin-cytarabine (CPX-351).
Am J Hematol
; 96(6): E196-E200, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33719090